Literature DB >> 7855225

A low dose of subcutaneous nicotine improves information processing in non-smokers.

J Le Houezec1, R Halliday, N L Benowitz, E Callaway, H Naylor, K Herzig.   

Abstract

Many studies have found that cigarette smoking or nicotine improves mental functioning in abstinent smokers. An unresolved issue is whether this improvement is due primarily to a direct facilitation of performance or to relief of the impairment caused by nicotine withdrawal. We evaluated the performance of 12 non-smokers before and twice (15 and 45 min) after a subcutaneous injection of 0.8 mg nicotine, 0.8 ml saline, and a control no treatment, on a choice reaction time (RT) task. Each treatment was given on a separate day; the control day was given on the first session. The order of nicotine and saline was balanced between subjects, and injections were given double-blind. The RT task manipulated stimulus and response processing. These manipulations consisted of two levels of stimulus complexity and two levels of response complexity, resulting in four task conditions. These manipulations along with latency measures of the event-related potential were used to identify the components of processing that mediated nicotine's effects on performance. During each active drug session blood nicotine levels, cardiovascular, and subjective responses were measured before and after each of the three tests (pre-drug, 15 min and 45 min post-drug). For the information processing measures only the comparisons of the pre- and 15-min post-test showed significant drug effects. Nicotine compared to saline significantly increased the number of responses at the fast end of the RT distribution. However, there were no changes in accuracy. Nicotine also speeded mean RT compared with saline or the control day, but the effects were only significant for the control-nicotine comparison.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7855225     DOI: 10.1007/bf02244994

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Visual event-related potentials index focused attention within bilateral stimulus arrays. II. Functional dissociation of P1 and N1 components.

Authors:  S J Luck; H J Heinze; G R Mangun; S A Hillyard
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1990-06

2.  Smoking motivation factos.

Authors:  A C McKennell
Journal:  Br J Soc Clin Psychol       Date:  1970-02

3.  A clinical pharmacological study of subcutaneous nicotine.

Authors:  J Le Houezec; P Jacob; N L Benowitz
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Effects of smoking on rapid information processing performance.

Authors:  K Wesnes; D M Warburton
Journal:  Neuropsychobiology       Date:  1983       Impact factor: 2.328

5.  On the dependence of P300 latency on stimulus evaluation processes.

Authors:  A Magliero; T R Bashore; M G Coles; E Donchin
Journal:  Psychophysiology       Date:  1984-03       Impact factor: 4.016

6.  Human information-processing: some effects of methylphenidate, age, and scopolamine.

Authors:  E Callaway
Journal:  Biol Psychiatry       Date:  1984-05       Impact factor: 13.382

7.  Effects of nicotine on stimulus sensitivity and response bias in a visual vigilance task.

Authors:  K Wesnes; D M Warburton; B Matz
Journal:  Neuropsychobiology       Date:  1983       Impact factor: 2.328

8.  The separate and combined effects of scopolamine and nicotine on human information processing.

Authors:  K Wesnes; A Revell
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Effects of oral scopolamine on human stimulus evaluation.

Authors:  E Callaway; R Halliday; H Naylor; G Schechter
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Nicotine pharmacokinetics and its application to intake from smoking.

Authors:  C Feyerabend; R M Ings; M A Russel
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

View more
  29 in total

1.  Effects of nicotine chewing gum on a real-life motor task: a kinematic analysis of handwriting movements in smokers and non-smokers.

Authors:  Oliver Tucha; Klaus W Lange
Journal:  Psychopharmacology (Berl)       Date:  2003-12-11       Impact factor: 4.530

2.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy.

Authors:  Craig D C Bailey; Mariella De Biasi; Paul J Fletcher; Evelyn K Lambe
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

4.  Faster P300 latency after smoking in visual but not auditory oddball tasks.

Authors:  M E Houlihan; W S Pritchard; J H Robinson
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

5.  Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers.

Authors:  J Foulds; J Stapleton; J Swettenham; N Bell; K McSorley; M A Russell
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

6.  C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency.

Authors:  Leslie K Jacobsen; Kenneth R Pugh; W Einar Mencl; Joel Gelernter
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

Review 7.  Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

Authors:  P A Newhouse; A Potter; E D Levin
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

Review 8.  Cognition enhancers in age-related cognitive decline.

Authors:  W J Riedel; J Jolles
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

9.  Effects of nicotine withdrawal on verbal working memory and associated brain response.

Authors:  Lawrence H Sweet; Richard C Mulligan; Colleen E Finnerty; Beth A Jerskey; Sean P David; Ronald A Cohen; Raymond S Niaura
Journal:  Psychiatry Res       Date:  2010-06-08       Impact factor: 3.222

Review 10.  Potential immunotherapies for sarcoidosis.

Authors:  Van Le; Elliott D Crouser
Journal:  Expert Opin Biol Ther       Date:  2018-01-17       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.